Non-Hodgkin Lymphoma News

• FDA Panel Urges Acrotech to Speed Up Study on Cancer Drugs A panel of independent experts to the US health regulator urged Acrotech Biopharma to work with the agency to bring forward the date for releasing trial data on company's blood cancer drugs.
  Reuters Health Information, November 16, 2023
• FDA Panel Voices Concerns Over Two Lymphoma Rushed Approvals 'The consensus of the advisory committee is that we have significant concerns about the very prolonged delay and getting these confirmatory studies underway.'
  MDedge News, November 17, 2023
• SITC 2023 T-Cell Cancers: CAR T Therapy to the Rescue? Scientists are seeing positive early results from treating relapsed/refractory T-cell blood cancers with un–gene-edited chimeric antigen receptor (CAR) T-cell therapy.
  MDedge News, November 09, 2023
• ESMO 2023 PD-1 Inhibitor Improves Outcomes in NHL Subtype Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.
  MDedge News, November 01, 2023
• Dupilumab-Associated Lymphoid Reactions Require Caution Retrospective study identifies potential for misdiagnosed mycosis fungoides and for dupilumab to fuel cutaneous lymphoid reactions that mimic mycosis fungoides in patients with atopic dermatitis.
  Medscape Medical News, October 30, 2023
• ESMO 2023 Ocular MALT Lymphoma: Radiation Reduces Relapse While relapse is common among patients with this type of lymphoma, those rates decline significantly with the addition of radiation therapy.
  MDedge News, October 30, 2023
• ESMO 2023 ALK Inhibitor Alectinib Shows DFS Benefit in Early NSCLC Interim findings from the ALINA trial show improved DFS with alectinib in the adjuvant setting vs chemotherapy in resected stage IB-IIIA NSCLC. But will early DFS results extend to overall survival?
  Medscape Medical News, October 22, 2023
• ESMO 2023 Remote Symptom Monitoring in Advanced Cancer Improves QoL Building on prior studies, a new trial shows that digital symptom monitoring during cancer treatment detects symptoms early, improves quality of life, and reduces hospital visits.
  Medscape Medical News, October 21, 2023
• ASTRO 2023 When to Treat DLBCL With Radiotherapy? Although radiation has become important in the treatment of diffuse large B cell lymphoma (DLBCL), radiologists highlight some the limitations of this approach.
  MDedge News, October 16, 2023
• Survival on the Upswing in Multiple Myeloma Hematologists are heralding a new era in multiple myeloma. Experts discuss how times have changed.
  MDedge News, October 12, 2023
• ASTRO 2023 Salvage Option to Replace Transplant in RR Hodgkin Lymphoma? A chemoimmunotherapy and radiation combination without autologous stem cell transplant produced high response rates in children and young adults with low-risk relapsed/refractory Hodgkin lymphoma.
  Medscape Medical News, October 03, 2023
• ADC Toxicities: The Price You Pay for Efficacy Understanding the toxicities associated with antibody-drug conjugates could help oncologists develop strategies to diminish adverse events that arise during treatment with these powerful agents
  Medscape Medical News, September 29, 2023
• SOHO 2023 Safely Skip PET2 After Brentuximab in Hodgkin Lymphoma? Recent data suggest that performing interim PET-CT in patients receiving frontline brentuximab vedotin plus chemotherapy generally does not affect patient management or outcomes.
  Medscape Medical News, September 13, 2023
• 'Promising' New Txs for Most Common Adult Leukemia Now there are encouraging signs that CLL could join the list of blood cancers that can be effectively treated with CAR T-cell therapy.
  MDedge News, September 11, 2023
• Atorvastatin Reduces Anthracycline-Associated Cardiotoxicity Study findings are encouraging, but the population was not diverse, and only one dose of atorvastatin was examined.
  Medscape Medical News, September 07, 2023
• CAR-T Therapy for NHL Treats Concurrent Rheumatic Disease CAR–T cell therapy for non-Hodgkin lymphoma appeared as safe and effective in patients with rheumatic autoimmune disease as in those without and also improved control of the underlying autoimmunity.
  Medscape Medical News, August 24, 2023
• Lymphoma Specialist to Lead MD Anderson’s Cancer Division "My research uncovered a series of physicians who served as 'clinical champions' and dramatically sped the process of drug development. This early career research inspired me to become the type of clinical champion that I uncovered."
  MDedge News, August 23, 2023
• Oral Cancer Drugs Requiring Prior Authorization on the Rise Over the past decade, the biggest increase in prior authorization occurred for non-specialty brand and generic drugs.
  Medscape Medical News, July 27, 2023
• Do Some Randomized Controlled Trials Stack the Deck? Patients in the control arm of cancer drug trials who progress are frequently not crossed over to the proven active therapy, leading to suboptimal care and problematic science, critics say.


  Medscape Medical News, July 27, 2023
• Indian Health Service Dermatologist Saw a Need to Serve Christopher Bengson, MD, MHS, a lieutenant commander in the US Public Health Service, accepted an offer to become a full-time dermatologist at Phoenix Indian Medical Center in Arizona.
  MDedge News, July 20, 2023
• New Trials in Leukemia and Lymphoma Enrolling Now Could one of your patients benefit from clinical trials now looking for patients with leukemia or lymphoma?
  Medscape Medical News, July 18, 2023